{"id":"NCT00721968","sponsor":"Glaukos Corporation","briefTitle":"Safety and Efficacy of the GTS400 Stent in Conjunction With Cataract","officialTitle":"A Prospective, Randomized, Controlled, Parallel Groups, Multicenter Clinical Investigation Of The Trabecular Micro-Bypass Stent Model GTS400 In Conjunction With Cataract Surgery","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03","primaryCompletion":"2012-02","completion":"2012-08","firstPosted":"2008-07-25","resultsPosted":"2014-03-06","lastUpdate":"2014-03-06"},"enrollment":62,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Open-angle Glaucoma"],"interventions":[{"type":"DEVICE","name":"Glaucoma Stent Surgery (GTS400 Stent)","otherNames":["GTS400 Stent"]},{"type":"PROCEDURE","name":"cataract surgery alone","otherNames":["Phacoemulsification"]}],"arms":[{"label":"1","type":"ACTIVE_COMPARATOR"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the safety and efficacy of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 in conjunction with cataract surgery, compared to cataract surgery only, in subjects with mild to moderate open angle glaucoma.","primaryOutcome":{"measure":"Month 12 Intraocular Pressure â‰¤ 18 mmHg Without Topical Hypotensive Medications","timeFrame":"12 months","effectByArm":[{"arm":"1 Treatment Group: iStent + Cataract Surgery","deltaMin":18,"sd":null},{"arm":"2 Control Group: Cataract Surgery Only","deltaMin":4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":27},"commonTop":["IOP increase >=10 mmHg versus baseline IOP at any visit","Posterior Capsule Opacification","Conjunctivitis","Corneal Abrasion","Iritis"]}}